>>> US Gapping Up

Gapping up
In reaction to earnings/guidance:

MAT +6.5%, AXP +6.2%, ICLR +5.9%, URI +5.2%, SXCP +5.2%, HXL +4.5%, CTXS +4.3%, SNA +4%
EXPO +3.7%, (also has approved an additional $35 million in share repurchases, adding toits existing $22 million available under the current authorization)
UMPQ +3.4%, RS +3.4%, KMI +3.3%, HLX +2.5%, FTI +2.4%, EWBC +2.1%, (light volume), DAN +2.1%, BK +2%,LRCX +1.8%, IMAX +1.8%, WBA +1.4%
ALK +1.4%, AAL +1.2%, KALU +1.1%, SON +0.8%, HNI +0.7%, LUV +0.7%, WDFC +0.6%, FNB +0.6%, TXT +0.6%

M&A news:

XGTI +9.2% ( to acquire Vislink Communication Systems for $16 mln)
IMOS +5.3% (announces it expects to close on October 31, 2016 the merger of ChipMOS Bermuda with and into its 58.3% owned subsidiary ChipMOS TECHNOLOGIES)
RAD +4.4% (Rite Aid and Walgreens Boots Alliance (WBA) mutually agree to extend the end date of their merger agreement from October 27 to January 27, 2017)

Select financial related names showing strength: IBN +2.9%, BBVA +1.8%, BCS +1.6%, RBS +1.3%, LYG +1.1%, .

Other news:

DRWI +44.8% (DragonWave announced Sprint has selected its microwave backhaul equipment for network deployment as part of the company's densification and optimization strategy)
IDXG +11.3% (thinly traded; reported today, from the ACG Annual Meeting in Las Vegas, NV, the publication of a study supporting its PanDNA product)
ABEO +3.9% (provides an update from the ABO-102 Phase 1/2 MPS IIIA clinical trial)
GALE +3.7% (announces that Dr. Doreen Jackson delivered a presentation on GALE-301 and GALE-302)
CBAY +2.8% (announces that MBX-8025 has been granted the PRIME designation by the EMA for the treatment of primary biliary cholangitis)
GNC +2.4% (continued strength)
AVGR +2.3% (receives expanded indications from the FDA recognizing the Pantheris Lumivascular atherectomy system as a technology that can be used for both therapeutic and diagnostic purposes)
ADXS +2.2% (initiates Part B of the KEYNOTE-046 clinical trial evaluating ADXS-PSA in combination with KEYTRUDA)

Analyst comments: